The Types segment categorises extended‑release protein technologies into four sub‑types: Microparticle, Nanoparticle, Matrix, and Coated systems. Microparticle formulations, typically ranging from 10–100 µm, dominate the market due to their established manufacturing processes and predictable release kinetics, accounting for the majority of type‑specific sales. Nanoparticle systems, below 1 µm, are gaining traction in medical nutrition because their high surface‑area‑to‑volume ratio enables precise modulation of protein release, albeit at higher production costs. Matrix technologies embed protein within biodegradable polymers, offering customizable degradation profiles that are valuable for functional food applications requiring multi‑phase release. Coated products apply a protective layer—often enteric or pH‑responsive—to standard protein powders, extending shelf life and targeting release to specific gastrointestinal zones. Each sub‑type contributes uniquely to the overall market size: microparticles drive volume, nanoparticles add premium value, matrix systems support niche functional claims, and coated products enhance product versatility across the application spectrum.